Cnpair Biotech — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

An antibody-focused biotech developing novel therapies for cancer and autoimmune diseases.

OncologyImmunology

Utilizes antibody discovery and engineering platforms to generate therapeutic candidates against cancer and immune targets.

Potential to address large oncology and autoimmune markets with novel biologic mechanisms.

High clinical development costs and risk of pipeline candidates failing in mid-to-late stage trials.

Enters a fiercely competitive global antibody market where differentiation on efficacy or safety is critical for success.